OneSavings Bank plc
(the Company)
NOTICE OF ANNUAL GENERAL MEETING
The following regulated information, disseminated pursuant to DTR6.3.5, comprises the Notice of Annual General Meeting for 2017 which was sent to shareholders of OneSavings Bank plc on 31 March 2017. A copy of the Notice of Annual General Meeting is available at www.osb.co.uk.
Enquiries:
OneSavings Bank plc
Nickesha Graham-Burrell
Deputy Company Secretary
t: 01634 835 796
Brunswick
t: 020 7404 5959
Robin Wrench / Simone Selzer
Notes to Editors
About OneSavings Bank plc
OneSavings Bank plc ('OSB') began trading as a bank on 1 February 2011 when the trade and assets of Kent Reliance Building Society were transferred into the business. OSB is a specialist lending and retail savings group authorised by the Prudential Regulation Authority, part of the Bank of England, and regulated by the Financial Conduct Authority and Prudential Regulation Authority.
OSB focuses on selected sub-sectors of the lending market in which it has established expertise, platforms and capabilities, and where opportunities have been identified for both high returns on a risk-adjusted basis and strong growth. These include Buy-to-Let/SME (comprising Buy-to-Let, Commercial, Residential development and Funding lines), Residential Mortgages (comprising First charge, Second charge and Funding lines), and Personal Loans. OSB originates organically through specialist brokers and independent financial advisors.
OSB is predominantly funded by retail savings originated through the established Kent Reliance franchise, which includes a network of branches in the South East of England, as well as online and postal channels. Diversification of funding is currently provided by securitisation and OSB joined the Funding for Lending Scheme in early 2014 and the Term Funding Scheme in November 2016.
THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt as to what action you should take, you are recommended to seek your own personal financial advice immediately from your stockbroker, bank manager, solicitor, accountant or other independent financial adviser who, if you are taking advice in the United Kingdom, is duly authorised under the Financial Services and Markets Act 2000, or an appropriately authorised independent financial adviser if you are in a territory outside the United Kingdom.
If you have sold or transferred all of your ordinary shares in OneSavings Bank plc, please send this document and any other documents that accompany it as soon as possible to the purchaser or transferee or to the stockbroker, bank or other agent through whom the sale or transfer was effected for transmission to the purchaser or transferee. If you have sold or otherwise transferred only part of your holding, you should retain this document and its enclosures.
Notice of Annual General Meeting
OneSavings Bank
(incorporated and registered in England and Wales under number 7312896. Registered office: Reliance House, Sun Pier, Chatham, Kent, ME4 4ET)
Notice of Annual General Meeting
on Wednesday, 10 May 2017 at 11 am
at the offices of Addleshaw Goddard LLP, Milton Gate,
60 Chiswell Street, London EC1Y 4AG
LETTER FROM THE CHAIRMAN
31 March 2017
Dear Shareholder
2016 ANNUAL REPORT AND ACCOUNTS AND 2017 ANNUAL GENERAL MEETING
I am pleased to inform you that the 2016 annual report and accounts and the notice of the 2017 annual general meeting of OneSavings Bank plc (the 'Company') have now been published. A copy of the 2016 Annual Report and Accounts for the year ended 31 December 2016 is enclosed with this document, together with a proxy form to enable you to exercise your voting rights.
This year's annual general meeting ('AGM') will be held at the offices of Addleshaw Goddard LLP, Milton Gate, 60 Chiswell Street, London EC1Y 4AG on Wednesday, 10 May 2017 at 11 am. Information on how to get to Addleshaw Goddard is included on the attendance card attached to the proxy form.
The formal notice of AGM is set out on pages 2 to 5 of this document and contains the proposed Resolutions. Explanatory notes to the business to be considered are set out from page 6 of this document.
VOTING AT THE AGM
This year I will once again be inviting you to vote on all Resolutions at the AGM by way of a poll rather than on a show of hands. Poll voting is in line with practice increasingly adopted by UK public companies and provides a more transparent method of voting. It will result in a more accurate reflection of the views of shareholders by ensuring that every vote is recognised, including the votes of those shareholders who are unable to attend but who have appointed a proxy for the meeting. On a poll each shareholder has one vote for every share held. I would encourage shareholders to exercise their right to vote.
ACTION TO BE TAKEN
If you would like to vote on the Resolutions to be proposed at the AGM but you are unable to attend in person, you can appoint another person as your proxy to exercise all or any of your rights to attend, vote and speak at the AGM by using one of the methods set out in the Notes section on page 10.
Whether or not you propose to attend the AGM, please complete and return the enclosed proxy form so that it is received by the Company's Registrar, Equiniti, by no later than 11 am on Monday, 8 May 2017. If you are a member of CREST, you may submit a proxy appointment electronically through the CREST voting service. Further details are set out in the Notes section on page 10. The appointment of a proxy will not stop you from attending the AGM and voting in person should you so wish.
The results of voting on the Resolutions will be posted on the Company's website following the conclusion of the meeting.
RECOMMENDATION
The Directors recommend shareholders to vote in favour of each of the Resolutions at the AGM. The Board considers that the Resolutions are in the best interests of the Company's shareholders as a whole and will promote the success of the Company for their benefit. The Directors intend to vote in favour of the Resolutions in respect of their own beneficial shareholdings in the Company (save in respect of those Resolutions in which they are interested).
Finally, as I will be stepping down at the conclusion of the AGM, I would like to thank you for your support over the years.
I look forward to seeing you at the AGM.
Yours faithfully
Mike Fairey
Chairman
NOTICE OF ANNUAL GENERAL MEETING
Notice is hereby given that the Annual General Meeting of OneSavings Bank plc (the 'Company') will be held at the offices of Addleshaw Goddard LLP, Milton Gate, 60 Chiswell Street, London EC1Y 4AG on Wednesday, 10 May 2017 at 11 am to consider and, if thought fit, pass the following Resolutions.
All Resolutions will be proposed as ordinary resolutions, save for Resolutions 10 to 14 inclusive which will be proposed as special resolutions.
1. To receive the audited financial statements and the Auditor's and Directors' reports for the year ended 31 December 2016.
2. To receive and approve the Annual Statement by the Chairman of the Remuneration Committee and the Annual Report on Directors' Remuneration for the financial year ended 31 December 2016.
3. To declare a final dividend of 7.6 pence per ordinary share in respect of the year ended 31 December 2016.
4. Election and re-election of Directors
To elect by separate resolutions each of the following as an independent non-executive Director of the Company:
(a) Andrew Doman
(b) Margaret Hassall
To re-elect by separate resolutions each of the following as a Director of the Company:
Independent non-executive Directors
(c) John Graham Allatt
(d) Eric Anstee
(e) Rodney Duke
(f) Mary McNamara
(g) Nathan Moss
Non-executive Director
(h) Timothy Hanford
Executive Directors
(i) Andrew Golding
(j) April Talintyre
5. To re-appoint KPMG LLP as the Auditor of the Company.
6. To authorise the Audit Committee to agree the remuneration of the Auditor.
7. That the Directors are generally and unconditionally authorised pursuant to and in accordance with section 551 of the Companies Act 2006 (the 'Act') to exercise all the powers of the Company to allot shares in the Company and to grant rights to subscribe for, or to convert any security into, shares in the Company ('Rights'):
a. up to a maximum aggregate nominal amount of £810,274; and
b. comprising equity securities (within the meaning of section 560 of the Act) up to a further maximum aggregate nominal amount of £810,274 in connection with an offer by way of a rights issue:
(i) to ordinary shareholders in proportion (as nearly as may be practicable) to their existing holdings; and
(ii) to the holders of other equity securities, as required by the rights of those securities or as the Directors otherwise consider necessary,
and subject to such exclusions or other arrangements as the Directors may deem necessary or expedient to deal with treasury shares, fractional entitlements, record dates or legal, regulatory or practical problems arising under the laws or the requirements of any regulatory body or stock exchange in any territory or by virtue of shares being represented by depositary receipts or any other matter.
This authority shall expire at the conclusion of the next annual general meeting of the Company, or, if earlier, at the close of business on 30 June 2018, save that the Company shall be entitled to make offers or agreements before the expiry of such authority which would or might require shares to be allotted or Rights to be granted after such expiry and the Directors shall be entitled to allot shares and grant Rights pursuant to any such offer or agreement as if this authority had not expired; and all authorities vested in the Directors on the date of the notice of this meeting to allot shares and grant Rights that remain unexercised at the commencement of this meeting are hereby revoked.
8. That, in addition to the authority contained in Resolution 7 in the notice of this meeting, the Directors are generally and unconditionally authorised pursuant to and in accordance with section 551 of the Companies Act 2006 (the 'Act') to exercise all the powers of the Company to allot shares in the Company and to grant rights to subscribe for, or to convert any security into, shares in the Company:
a. up to a maximum aggregate nominal amount of £291,698 in relation to the issue of Regulatory Capital Convertible Instruments; and
b. subject to applicable law and regulation, at such conversion prices (or such maximum or minimum conversion prices or conversion price methodologies) as may be determined by the Directors of the Company from time to time.
This authority shall expire at the conclusion of the next annual general meeting of the Company or, if earlier, at the close of business on 30 June 2018), save that the Company shall be entitled to make offers or agreements before the expiry of such authority which would or might require shares to be allotted or rights to be granted after such expiry and the Directors may allot shares and grant rights to subscribe for or to convert any security into shares, in pursuance of any such offer or agreement as if the authority had not expired.
9. That, in accordance with sections 366 and 367 of the Companies Act 2006 (the 'Act'), the Company and all companies that are its subsidiaries, at any time up to the conclusion of the next annual general meeting or, if earlier, up to the close of business on 30 June 2018, are authorised to:
a. make political donations to political parties and/or independent election candidates;
b. make political donations to political organisations other than political parties; and
c. incur political expenditure;
up to an aggregate total amount of £50,000, with the amount authorised for each of heads (a) to (c) above being limited to the same total.
For the purposes of this authority the terms 'political donation', 'political parties', 'independent election candidates', 'political organisation' and 'political expenditure' have the meanings given by sections 363 to 365 of the Act.
10. That, subject to the passing of Resolution 7 in the notice of this meeting, the Directors are empowered pursuant to sections 570 and 573 of the Companies Act 2006 (the 'Act') to allot equity securities (within the meaning of section 560 of the Act) for cash either pursuant to the authority conferred by Resolution 7 in the notice of this meeting or by way of a sale of treasury shares as if section 561(1) of the Act did not apply to any such allotment or sale provided that this power shall be limited to:
a. the allotment of equity securities and the sale of treasury shares in connection with an offer of or invitation to acquire equity securities (but in the case of the authority granted under sub-paragraph (b) of Resolution 7 in the notice of this meeting by way of a rights issue only):
(i) to the holders of ordinary shares in proportion (as nearly as may be practicable) to their existing holdings; and
(ii) to the holders of other equity securities, as required by the rights of those securities or as the Directors otherwise consider necessary,
and subject to such exclusions or other arrangements as the Directors may deem necessary or expedient to deal with treasury shares, fractional entitlements, record dates or legal, regulatory or practical problems arising under the laws of or the requirements of any regulatory body or stock exchange in any territory or by virtue of shares being represented by depositary receipts or any other matter; and
b. the allotment (otherwise than pursuant to sub-paragraph (a) of this Resolution 10) to any person or persons of equity securities or sale of treasury shares up to a maximum aggregate nominal amount of £121,541.
Such power shall expire on the revocation or expiry (unless renewed) of the general authority conferred on the Directors by Resolution 7 in the notice of this meeting, save that the Company shall be entitled to make offers or agreements before the expiry of such power which would or might require equity securities to be allotted after such expiry and the Directors shall be entitled to allot equity securities pursuant to any such offer or agreement as if the power conferred hereby had not expired.
11. That, subject to the passing of Resolution 7 in the notice of this meeting and in addition to the power contained in Resolution 10 in the notice of this meeting, the Directors are empowered pursuant to sections 570 and 573 of the Companies Act 2006 (the 'Act') to allot equity securities (within the meaning of section 560 of the Act) for cash pursuant to the authority conferred by Resolution 7 in the notice of this meeting or by way of a sale of treasury shares as if section 561(1) of the Act did not apply, provided that this power is:
a. limited to the allotment of equity securities or sale of treasury shares up to an aggregate nominal value of £121,541; and
b. used only for the purposes of financing (or refinancing, if the power is to be exercised within six months after the date of the original transaction) a transaction which the Directors determine to be an acquisition or other capital investment of a kind contemplated by the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the Pre-Emption Group prior to the date of the notice of this meeting.
Such power shall expire on the revocation or expiry (unless renewed) of the authority conferred on the Directors by Resolution 7 in the notice of this meeting, save that the Company shall be entitled to make offers or agreements before the expiry of such power which would or might require equity securities to be allotted after such expiry and the Directors shall be entitled to allot equity securities pursuant to any such offer or agreement as if the power conferred hereby had not expired.
12. That, subject to the passing of Resolution 8 in the notice of this meeting and in addition to the powers contained in Resolutions 10 and 11 in the notice of this meeting, the Directors are empowered pursuant to sections 570 and 573 of the Companies Act 2006 (the 'Act') to allot equity securities (within the meaning of section 560 of the Act) for cash either pursuant to the authority conferred by Resolution 8 in the notice of this meeting or by way of a sale of treasury shares as if section 561 of the Act did not apply to any such allotment or sale.
Such power shall expire on the revocation or expiry (unless renewed) of the authority conferred on the Directors by Resolution 8 in the notice of this meeting, save that the Company shall be entitled to make offers or agreements before the expiry of such power which would or might require equity securities to be allotted after such expiry and the Directors shall be entitled to allot equity securities pursuant to any such offer or agreement as if the power conferred hereby had not expired.
13. That the Company is generally and unconditionally authorised for the purpose of section 701 of the Companies Act 2006 (the 'Act') to make market purchases (within the meaning of section 693(4) of the Act) of ordinary shares of £0.01 each in the capital of the Company on such terms and in such manner as the Directors may from time to time determine, provided that:
a. the maximum aggregate number of ordinary shares hereby authorised to be acquired is 24,308,209;
b. the minimum price (excluding expenses) which may be paid for any such share is £0.01;
c. the maximum price (excluding expenses) which may be paid for any such share is the higher of (i) an amount equal to 5% above the average of the middle market quotations for an ordinary share in the Company as derived from The London Stock Exchange Daily Official List for the five business days immediately preceding the day on which such share is contracted to be purchased; and (ii) the higher of the price of the last independent trade of an ordinary share and the highest current independent bid for an ordinary share in the Company on the trading venues where the market purchases by the Company is carried out);
d. the authority hereby conferred shall expire at the conclusion of the next annual general meeting or, if earlier, at the close of business on 30 June 2018 unless previously renewed, varied or revoked by the Company in general meeting; and
e. the Company may, before this authority expires, make a contract to purchase its ordinary shares which would or might be executed wholly or partly after the expiry of this authority, and may purchase its ordinary shares pursuant to it as if this authority had not expired.
14. That a general meeting of the Company, other than an annual general meeting, may be called on not less than 14 clear days' notice.
By Order of the Board
Jason Elphick
Group General Counsel and Company Secretary
31 March 2017
Registered Office:
Reliance House
Sun Pier
Chatham
Kent ME4 4ET
EXPLANATORY NOTES
Information about the business to be considered at the AGM is set out below.
These explanatory notes should be read in conjunction with the 2016 Annual Report and Accounts. This Notice of AGM and the Annual Report and Accounts are available at www.osb.co.uk. For the purpose of this Notice, the issued share capital of the Company with voting rights on 24 March 2017, being the latest practicable date prior to the printing of this document, was 243,082,091 ordinary shares of £0.01 each.
RESOLUTION 1: 2016 Annual Report and Accounts (ordinary resolution)
The Directors of the Company present the Directors' reports, the Auditor's report and the audited financial statements of the Company for the financial year ended 31 December 2016 (the '2016 Annual Report and Accounts') to the AGM as required by the Companies Act 2006. In accordance with the UK Corporate Governance Code, the Company proposes, as an ordinary resolution, a resolution on the 2016 Annual Report and Accounts and shareholders may raise any questions on the 2016 Annual Report and Accounts under this Resolution.
RESOLUTION 2: Annual Statement by the Chair of the Remuneration Committee and the Annual Report on Directors' Remuneration for the period ended 31 December 2016 (ordinary resolution)
In accordance with the Companies Act 2006, shareholders are invited to approve the Annual Statement by the Chair of the Remuneration Committee and the Annual Report on Directors' Remuneration for the financial year ended 31 December 2016. The Annual Statement and to Report, which may be found on pages 77 to 84 of the 2016 Annual Report and Accounts, give details of your Directors' remuneration for the year ended 31 December 2016 and set out the way in which the Company implemented its policy on Directors' remuneration. The Auditor has audited those parts of the Annual Report on Directors' Remuneration capable of being audited and its report can be found on pages 94 to 98 of the 2016 Annual Report and Accounts, which can be accessed on the Company's website at www.osb.co.uk. The vote on Resolution 2 is advisory only and the Directors' entitlement to remuneration is not conditional on it being passed.
The Companies Act 2006 requires the Directors' Remuneration Policy to be put to shareholders for approval annually unless the approved policy remains unchanged, in which case it need only be put to shareholders for approval at least every three years. The Company is not proposing any changes to the Directors' Remuneration Policy approved at the annual general meeting in 2015.
RESOLUTION 3: Final dividend (ordinary resolution)
A final dividend of 7.6 pence per ordinary share has been recommended by the Board for the year ended 31 December 2016 and, if approved by shareholders, will be paid on 17 May 2017 to all shareholders on the register at the close of business on 31 March 2017.
RESOLUTIONS 4 (a) to (j) Election and Re-election of Directors (ordinary resolutions)
Resolutions 4 (a) to (j) relate to the retirement and election or re-election of the Company's Directors. The Company's articles of association require a Director who has been appointed by the Board during the year to retire at the annual general meeting next following his or her appointment. Both Andrew Doman and Margaret Hassall have been appointed since the last annual general meeting. Consequently, both will retire from office at the AGM and are seeking election as independent non-executive Directors.
The Company's articles of association also require any Director who has not been elected or re-elected by the Company's shareholders at either of the two preceding annual general meetings to retire at the next annual general meeting. Notwithstanding the provisions of the Company's articles of association, the Board has determined that, in line with best practice recommendations of the UK Corporate Governance Code for FTSE 350 companies, each of the remaining Directors shall retire from office at the AGM and each shall stand for re-election by the shareholders, with the exception of Mike Fairey who shall step down from the Board at the conclusion of the AGM.
The Board has confirmed, following a performance review, that each of the Directors standing for election or re-election continues to be an effective member of the Board, to make a positive contribution and to demonstrate commitment to his or her role. The Board believes that the considerable and wide-ranging experience of the Directors will continue to be invaluable to the Company. The biographies of Directors can be found in the Appendix to this document and also on the Company's website www.osb.co.uk.
Resolutions 4 (a) to (g) (inclusive) relate specifically to the election and re-election of those Directors that the Board has determined are independent for the purposes of the UK Corporate Governance Code (the 'Independent Non-Executive Directors'). Under the Financial Conduct Authority's Listing Rules, a company that has a controlling shareholder (being any person who exercises or controls, on their own or together with any person with whom they are acting in concert, 30% or more of the votes able to be cast on all or substantially all matters at general meetings of the Company) must, for the purposes of the election or re-election of an independent non-executive director, pass both an ordinary resolution of all shareholders and a separate ordinary resolution of all shareholders other than the controlling shareholders.
As at 24 March 2017, OSB Holdco Limited held 53.78% of the Company's issued share capital and is therefore considered to be a controlling shareholder of the Company. As such, this year the election and re-election of the Company's seven Independent Non-Executive Directors must be approved in each case by a majority vote of both: (a) the Company's shareholders as a whole; and (b) the Company's shareholders entitled to vote on the election and re-election of Directors other than OSB Holdco Limited or any of OSB Holdco Limited's associates (the 'Independent Shareholders'). Resolutions 4 (a) to (g) (inclusive), are therefore being proposed as ordinary resolutions on which all shareholders may vote. When they have done so, the separate Independent Shareholder vote will be obtained by excluding from the result of the vote on each resolution, the votes of the controlling shareholder of the Company. The Company will, on announcing the result of the AGM, announce the result of both the vote of all the Company's shareholders and the vote of the Independent Shareholders. If the ordinary resolution to approve the election or re-election of an independent non-executive director is passed, but the separate approval by the independent shareholders is not given, a further ordinary resolution may be put forward to be approved by the shareholders as a whole at a general meeting which must be held more than 90 days after the date of the first vote but within 120 days of that first vote. Accordingly, if any of Resolutions 4 (a) to (g) (inclusive), is not approved by a majority vote of the Independent Shareholders at the AGM, the relevant Independent Non-Executive Director will be treated as having been re-elected only for the period from the date of the AGM until the earlier of (i) the close of any general meeting of the Company, convened for a date more than 90 days after the AGM but within 120 days of the AGM, to propose a further ordinary resolution to re-elect him or her; (ii) the date which is 120 days after the AGM; and (iii) the date of any announcement by the Board that it does not intend to hold a second vote. In the event that the Independent Non-Executive Director's re-election is approved by majority vote of all shareholders at a second meeting, the Independent Non-Executive Director in question will be re-elected until the Company's next annual general meeting.
As required by the Listing Rules, the Company confirms the following:
1. Andrew Doman holds office as Chairman of Castle Trust Capital plc (Castle Trust), a company controlled by J.C. Flowers & Co which is a significant shareholder in the Company. Tim Hanford, a non-executive Director of the Company nominated by J.C. Flowers & Co, is also a director of Castle Trust. Tim Hanford is not considered by the Board to be independent and is not subject to the separate approval of the Independent Shareholders. Otherwise, there are no existing relationships, transactions or arrangements between any of the Independent Non-Executive Directors and the Company, any of the Company's Directors, OSB Holdco Limited or any of OSB Holdco Limited's associates.
2. There are no previous relationships, transactions or arrangements between the Independent Non-Executive Directors and the Company, any of the Company's Directors, OSB Holdco Limited or any of OSB Holdco Limited's associates.
3. The effectiveness of all the Company's Directors is assessed as part of the Board performance evaluation process. Each of the Independent Non-Executive Directors possesses a wide range of skills and expertise (as noted in the Appendix to this document) that is highly valued by the Board. The Independent Non-Executive Directors continue to contribute effectively to the operation of the Board and to demonstrate commitment to their roles.
4. The Company assesses the independence of its Non-Executive Directors in accordance with the recommendations of the UK Corporate Governance Code. The Company determined that the Independent Non-Executives Directors were independent on their appointment to the Board and ensures that they remain independent by periodically reviewing their character, judgment and the various relationships referred to above. In particular, at the time of Andrew Doman's appointment to the board of Castle Trust, the Board assessed the relationships between the Company and Castle Trust, between Andrew Doman and Tim Hanford and between Andrew Dorman and J.C. Flowers & Co and determined (and remains satisfied) that Andrew Doman is able to apply objective, unfettered and independent judgment and to act in the best interests of the Company.
5. The Nomination and Governance Committee of the Company's Board is responsible for keeping the size, structure and composition of the Board under review. By reference to the Company's requirements, the Nomination and Governance Committee is responsible for identifying, evaluating and recommending candidates for appointment to the Board. The selection process involves establishing the criteria for any new Director appointment, the briefing of an independent recruitment consultancy that is engaged to provide a shortlist of suitable candidates, the consideration by the Nomination and Governance Committee of potential candidates, followed by interviews with Non-Executive Directors and senior management. The Nomination and Governance Committee will then make any appointment recommendations to the Board. This procedure was followed in the recruitment of both Andrew Doman and Margaret Hassall during the year.
RESOLUTIONS 5 AND 6: Appointment and remuneration of the Auditor (ordinary resolutions)
The Company is required to appoint the Auditor at each general meeting at which accounts are laid before the Company, to hold office until the conclusion of the next such meeting. Resolution 5 proposes the re-appointment of KPMG LLP as the Auditor of the Company and Resolution 6 authorises the Audit Committee to agree the remuneration of the Auditor.
RESOLUTION 7: Directors' authority to allot shares (ordinary resolution)
The Directors currently have a general authority to allot new ordinary shares in the capital of the Company and to grant rights to subscribe for, or convert any securities into, shares. This authority is, however, due to expire at the AGM and the Board would like to renew it to provide the Directors with flexibility to allot new shares and grant rights up until the Company's next annual general meeting within the limits prescribed by The Investment Association.
The Investment Association's guidelines on Directors' authority to allot shares state that the Association's members will regard as routine any proposal at a general meeting to seek a general authority to allot an amount up to two-thirds of the existing share capital, provided that any amount in excess of one-third of the existing share capital is applied to fully pre-emptive rights issues only. Accordingly, if passed, this resolution will authorise the Directors to allot (or grant rights over) new shares in the Company: (i) under an open offer or in other situations (including a rights issue) up to an aggregate nominal amount of £810,274 (representing approximately 33 per cent. of the Company's issued ordinary share capital); and (ii) under a rights issue only, up to a further aggregate nominal amount of £810,274 (representing approximately 33 per cent. of the Company's issued ordinary share capital. In each case, the reference to the Company's issued ordinary share capital is to the issued ordinary share capital as at 24 March 2017 (being the latest practicable date prior to publication of this document).
If passed, this authority will expire at the conclusion of the annual general meeting in 2018 or, if earlier, at the close of business on 30 June 2018. The Directors have no present intention of exercising this authority, however the Board considers it prudent to maintain the flexibility that it provides to enable the Directors to respond to any appropriate opportunities that may arise. The Company did not hold any shares in treasury as at 24 March 2017.
RESOLUTION 8: Directors' authority to allot shares in relation to the issue of Regulatory Capital Convertible Instruments (ordinary resolution)
This Resolution renews the Directors' authority to allot shares or grant rights to subscribe for or convert any security into ordinary shares up to an aggregate nominal amount of £291,698 in connection with the issue of 'Regulatory Capital Convertible Instruments'. Regulatory Capital Convertible Instruments are any securities to be issued by the Company or any member of the Group, or by a Company outside of the Group with the consent of the Company or a member of the Group and which are intended on issue to form all or part of a type or class of securities the terms of which are eligible to meet any Regulatory Capital Requirements and which are:
a) convertible into or exchangeable for ordinary shares of the Company; or
b) issued together with share warrants relating to ordinary shares of the Company,
and in each case, which grant to, or require, the holder of such security and/or its nominee a right or obligation (as applicable) to subscribe for such ordinary shares following a specified event relating to an actual or prospective adverse change in the capital position or viability of the Company, any member of the Group or the Group as a whole or any other event specified in the Regulatory Capital Requirements and otherwise on such terms as may be determined by the Directors of the Company or a committee thereof upon issue.
The Board believes it is in the best interests of the Company to have the flexibility to issue Regulatory Capital Convertible Instruments at any time and from time to time. The authority sought in this Resolution will be used as considered desirable to comply with or maintain compliance with such Regulatory Capital Requirements or targets applicable to the Company. Regulatory Capital Requirements are specified by the Prudential Regulation Authority or other such authority having primary supervisory authority with respect to the Company from time to time in relation to the margin of solvency, capital resources, capital, contingent capital or buffer capital of the Company, a member of the Group or the Group taken as a whole.
The Company intends to seek to renew authority for the issuance of such Regulatory Capital Convertible Instruments on an annual basis.
The amount of this authority is, in aggregate, equivalent to approximately 12% of the issued ordinary share capital of the Company as at 24 March 2017 (being the latest practicable date before the publication of this document). No ordinary shares were held in treasury as at that date.
Resolutions 8 and 12 are intended to provide the Directors with the flexibility to authorise the issue of Regulatory Capital Convertible Instruments which contain contractual debt to equity conversion features. The Resolutions are not intended to provide authority for any future UK statutory conversion requirements as may become part of UK national law in the future, for which such authority would not be required.
This is separate and distinct from the authority sought in Resolution 7 which is the usual authority sought on an annual basis in line with guidance issued by the Investment Association.
Conditional upon the passing of Resolutions 8 and 12, the Directors would not expect to make use of Resolutions 7 and 10 to issue Regulatory Capital Convertible Instruments, although these Resolutions may be used for other purposes and, if so used, would have the effect of diluting the interests of ordinary shareholders.
RESOLUTION 9: Authority to make political donations (ordinary resolution)
Neither the Company nor any of its subsidiaries made any political donations during 2016. It is not proposed or intended to alter the Company's policy of not making political donations, within the normal meaning of that expression. However, some of the Company's activities may potentially fall within the wide definition of a political donation in the Companies Act 2006 and, without the necessary statutory authorisation, the Company's ability to communicate its views effectively to political audiences and to relevant interest groups could be inhibited. Such activities may include briefings at receptions or conferences - when the Company seeks to communicate its views on issues vital to its business interests - including, for example, conferences of a party political nature or of special interest groups in specific areas.
Accordingly, the Company believes that the authority contained in this Resolution is necessary to allow it and its subsidiaries to fund activities which it is in the interests of shareholders that the Company should support. Such authority will enable the Company and its subsidiaries to be sure that they do not, because of any uncertainty as to the bodies or the activities covered by the Companies Act 2006, unintentionally commit a technical breach of the statutes. Any expenditure which may be incurred under authority of this Resolution will be disclosed in next year's annual report and accounts.
RESOLUTIONS 10 and 11: Disapplication of statutory pre-emption rights (special resolutions)
Resolutions 10 and 11 are special resolutions which, if passed by shareholders, will enable the Directors to allot ordinary shares in the Company, or to sell any shares out of treasury, for cash, without first offering those shares to existing shareholders in proportion to their existing holdings.
In March 2015, the Pre-Emption Group published a revision of its Statement of Principles. In addition to restating the customary five per cent. limit on the issuance of shares for cash on a non pre-emptive basis, the 2015 Statement of Principles introduced greater flexibility for companies to undertake non pre-emptive issues for cash in connection with acquisitions and specified capital investments. This relaxation allows companies the opportunity to finance expansion opportunities as and when they arise.
The 2015 Statement of Principles provides that a company may now seek power to issue on a non pre-emptive basis for cash shares representing:
(i) no more than five per cent of the company's issued ordinary share capital in any one year; and
(ii) no more than an additional five per cent. of the company's issued ordinary share capital provided that such additional power is only used in connection with an acquisition or specified capital investment.
The 2015 Statement of Principles defines a "specified capital investment" as "one or more specific capital investment related uses for the proceeds of an issuance of equity securities, in respect of which sufficient information regarding the effect of the transaction on the listed company, the assets the subject of the transaction and (where appropriate) the profits attributable to them is made available to shareholders to enable them to reach an assessment of the potential return." Items that are regarded as operating expenditure rather than capital expenditure will not typically be regarded as falling within the term "specified capital investment".
At the annual general meeting in 2016, the Company sought, through a single special resolution, power to disapply pre-emption rights in accordance with the flexibility permitted by the 2015 Statement of Principles. The Company intends to seek such power again at the AGM. This year, in line with best practice, the Company intends to structure its pre-emption disapplication request as two separate resolutions.Resolution 10 is proposed as a special resolution. If this resolution is passed by shareholders, it will permit the Directors to allot ordinary shares on a non pre-emptive basis and for cash (otherwise than in connection with a rights issue or similar pre-emptive issue) up to a maximum nominal amount of £121,541. This amount represents approximately five per cent of the Company's issued ordinary share capital as at 24 March 2017 (being the latest practicable date prior to publication of this document). This resolution will permit the Directors to allot any such shares for cash in any circumstances (whether or not in connection with an acquisition or specified capital investment).
Resolution 11 is also proposed as a separate special resolution. If this resolution is passed by shareholders, it will afford the Directors an additional power to allot ordinary shares on a non pre-emptive basis and for cash up to a further maximum nominal amount of £121,541. This amount also represents approximately five per cent of the Company's issued ordinary share capital as at 24 March 2017. The Directors shall use any power conferred by Resolution 11 only in connection with an acquisition or a specified capital investment which is announced contemporaneously with the issue, or which has taken place in the preceding six month period and is disclosed in the announcement of the issue.
The Directors confirm their intention to follow the provisions of the 2015 Statement of Principles regarding cumulative usage of authorities within a rolling three year period. Those Principles provide that a company should not issue shares for cash representing more than 7.5% of the company's issued share capital in any rolling three year period, other than to existing shareholders, without prior consultation with shareholders. This limit excludes any ordinary shares issued pursuant to a general disapplication of pre-emption rights in connection with an acquisition or specified capital investment.
RESOLUTION 12: Disapplication of statutory pre-emption rights in relation to the issue of Regulatory Capital Convertible Instruments (special resolution)
Resolution 8 renews the Directors' authority to allot shares or grant rights to subscribe for or convert any security into ordinary shares up to an aggregate nominal amount of £291,698 specifically in connection with the issue of Regulatory Capital Convertible Instruments. Resolution 12 proposes that the Directors be empowered to allot equity securities pursuant to that authority for cash, without first offering those equity securities to existing shareholders in proportion to their existing holdings. £291,698 is equivalent to approximately 12% of the issued ordinary share capital of the Company as at 24 March 2017 (being the latest practicable date before the publication of this document).
Renewing this Resolution will permit the Company the flexibility necessary to allot equity securities pursuant to any proposal to issue Regulatory Capital Convertible Instruments and, by virtue of such disapplication, without the need to comply with the pre-emption requirements of the UK statutory regime.
RESOLUTION 13: Authority to purchase own shares (special resolution)
Resolution 13 gives the Company authority to buy back its own ordinary shares in the market as permitted by the Companies Act 2006.
The authority limits the maximum number of shares that could be purchased to 24,308,209 (representing approximately 10% of the Company's issued ordinary share capital as at 24 March 2017) and sets minimum and maximum prices at which shares may be purchased.
This authority will expire at the conclusion of the annual general meeting of the Company in 2018 or, if earlier, at the close of business on 30 June 2018. A listed company purchasing its own shares may hold those shares in treasury and make them available for re-sale as an alternative to cancelling them. Accordingly, if this Resolution is passed, the Company will have the option of holding, as treasury shares, any of its own shares that it purchases pursuant to the authority conferred. This would give the Company the ability to sell treasury shares quickly and cost-effectively and provide the Company with additional flexibility in the management of its capital base. No dividends are paid and no voting rights are attached to shares held in treasury. The Company did not hold any shares in treasury as at 24 March 2017 (being the latest practicable date before the publication of this document). As at 24 March 2017, there were 1,468,338 options to subscribe for ordinary shares in the capital of the Company, representing 0.60% of the Company's issued ordinary share capital. If the full authority conferred by this Resolution were to be exercised in full, these options would represent 0.67% of the issued ordinary share capital of the Company. The Directors have no present intention of exercising the authority to purchase the Company's ordinary shares for cancellation, but may purchase shares to be held in treasury.
The Directors have no present intention of exercising this authority, but wish to have the flexibility to do so in the future. Shares would only be purchased if the Directors believed that to do so would result in an improvement in earnings per share and would be in the interests of shareholders generally. Any purchases of ordinary shares would be by means of market purchases on a recognised investment exchange.
RESOLUTION 14: Notice of general meetings (special resolution)
Changes made to the Companies Act 2006 by the Shareholders' Rights Regulations increase the notice period required for general meetings of the Company to at least 21 clear days unless shareholders approve a shorter notice period, which cannot however be less than 14 clear days (annual general meetings will continue to be held on at least 21 clear days' notice). At last year's annual general meeting, shareholders passed a resolution enabling the Company to call general meetings, other than an annual general meeting, on at least 14 clear days' notice. This approval must be renewed at each annual general meeting, so, in order to preserve this ability, Resolution 14 seeks such approval. It is intended that the shorter notice period would not be used as a matter of routine for such meetings but only where the flexibility is merited by the business of the meeting and is thought to be in the interests of shareholders as a whole. If given, the approval will be effective until the Company's next annual general meeting, when it is intended that a similar resolution will be proposed.
NOTES
1. Only persons entered on the register of shareholders of the Company at 6.30 pm on Monday, 8 May 2017 (or, if the AGM is adjourned, at 6.30 pm on the date which is two business days prior to the adjourned meeting) shall be entitled to attend and vote at the AGM or adjourned meeting. Changes to entries on the register after this time shall be disregarded in determining the rights of persons to attend or vote (and the number of votes they may cast) at the AGM or adjourned meeting. Shareholders who are deemed to be controlling shareholders (as defined in LR 6.1.2AR of the Financial Conduct Authority's Listing Rules) as at 6.30 pm on Monday, 8 May 2017 shall not be entitled to vote in respect of the separate approval of Resolutions 4 (a) to (g) (inclusive) by shareholders who are not controlling shareholders in accordance with LR 9.2.2ER (2) of the Listing Rules.
2. A shareholder entitled to attend and vote at the AGM may appoint another person as her/his proxy to exercise all or any of her/his rights to attend, speak and vote at the AGM. A shareholder can appoint more than one proxy in relation to the AGM, provided that each proxy is appointed to exercise the rights attached to a different share or shares held by that shareholder.
3. A proxy does not need to be a shareholder of the Company but must attend the AGM to represent you. Your proxy could be the Chairman or another person who has agreed to attend to represent you. If you wish for a proxy to make any comments on your behalf at the AGM, you will need to appoint someone other than the Chairman of the meeting and give them the relevant instructions directly. The valid appointment of a proxy does not prevent you from attending the AGM and voting in person.
4. A shareholder who wishes to appoint a proxy should complete the Form of Proxy which accompanies this notice and includes full details of how to appoint a proxy. If you do not have a Form of Proxy and believe that you should have one, or if you require additional Forms of Proxy, please contact Equiniti's helpline on 0371 384 2701 (+44 121 415 7047 if calling from overseas) (Lines are open between 8.30 am and 5.30 pm Monday to Friday). Shareholders who hold their shares in uncertificated form may use "the CREST voting service" to appoint a proxy electronically, as explained below.
5. In order to be valid, a proxy appointment must be returned (together with any power of attorney or other authority under which it is executed or a copy of the authority certified in ink by a bank, a stockbroker or a solicitor) by one of the following methods:
· in hard copy form by post, by courier or by hand to the Company's registrar at the address shown on the Form of Proxy; or
· in the case of CREST members, by utilising the CREST electronic proxy appointment service in accordance with the procedures set out in note 8 below.
The appointment of a proxy in each case must formally be received by the Company's registrar no later than 11 am on Monday, 8 May 2017.
6. To change your proxy instructions you may return a new proxy appointment using the methods set out above. Where you have appointed a proxy using the hard copy Form of Proxy and would like to change the instructions using another hard copy Form of Proxy, please contact Equiniti at Aspect House, Spencer Road, Lancing, West Sussex BN99 6DA. The deadline for receipt of proxy appointments (see above) also applies in relation to amended instructions. Any attempt to terminate or amend a proxy appointment received after the relevant deadline will be disregarded. Where two or more valid separate appointments of proxy are received in respect of the same share in respect of the same meeting, the one which is last sent shall be treated as replacing and revoking the other or others. If the Company is unable to determine which is last sent, the one which is last received shall be so treated. If the Company is unable to determine either which is last sent or which is last received, none of them shall be treated as valid in respect of the relevant share(s).
7. A copy of this notice has been sent for information only to Nominated Persons (that is, a person who has been nominated by a shareholder to enjoy information rights under section 146 of the Companies Act 2006). The rights to appoint a proxy cannot be exercised by a Nominated Person; they can only be exercised by a shareholder. However, a Nominated Person may have a right under an agreement with the shareholder by whom s/he was nominated to be appointed as a proxy for the AGM or to have someone else so appointed. If a Nominated Person does not have such a right or does not wish to exercise it, s/he may have a right under such an agreement to give instructions to the shareholder as to the exercise of voting rights.
8. CREST members who wish to appoint a proxy or proxies by utilising the CREST electronic proxy appointment service may do so by utilising the procedures described in the CREST Manual, which can be viewed at www.euroclear.com. CREST personal members or other CREST sponsored members, and those CREST members who have appointed a voting service provider(s), should refer to their CREST sponsor or voting service provider(s), who will be able to take the appropriate action on their behalf. In order for a proxy appointment made by means of CREST to be valid, the appropriate CREST message (a 'CREST Proxy Instruction') must be properly authenticated in accordance with Euroclear's specifications and must contain the information required for such instructions, as described in the CREST Manual. The message regardless of whether it constitutes the appointment of a proxy or an amendment to the instruction given to a previously appointed proxy must, in order to be valid, be transmitted so as to be received by the issuer's agent (ID number RA19) by 11 am on Monday, 8 May 2017 (the latest time(s) for receipt of proxy appointments specified in this notice). For this purpose, the time of receipt will be taken to be the time (as determined by the timestamp applied to the message by the CREST Applications Host) from which the issuer's agent is able to retrieve the message by enquiry to CREST in the manner prescribed by CREST. The Company may treat as invalid a CREST Proxy Instruction in the circumstances set out in regulation 35(5)(a) of the CREST Regulations.
9. CREST members and, where applicable, their CREST sponsors or voting service providers should note that Euroclear does not make available special procedures in CREST for any particular messages. Normal system timings and limitations will therefore apply in relation to the input of CREST Proxy Instructions. It is the responsibility of the CREST member concerned to take (or, if the CREST member is a CREST personal member or sponsored member or has appointed a voting service provider(s), to procure that his CREST sponsor or voting service provider(s) take(s)) such action as shall be necessary to ensure that a message is transmitted by means of the CREST system by any particular time. In this connection, CREST members and, where applicable, their CREST sponsors or voting service providers are referred, in particular, to those sections of the CREST Manual concerning practical limitations of the CREST system and timings.
10. Voting on all Resolutions will be conducted by way of a poll rather than a show of hands. This is a more transparent method of voting as shareholders' votes are to be counted according to the number of shares held. As soon as practicable following the AGM, the results of the voting will be announced via a Regulatory Information Service and also placed on the Company's website: www.osb.co.uk on the 'Shareholder Information' page.
11. Please note that the Company takes all reasonable precautions to ensure no viruses are present in any electronic communication it sends out but the Company cannot accept responsibility for loss or damage arising from the opening or use of any email or attachments from the Company and recommends that the shareholders subject all messages to virus checking procedures prior to use. Any electronic communication received by the Company, including the lodgement of an electronic proxy form, that is found to contain any virus will not be accepted.
12. A shareholder of the Company, which is a corporation, may authorise a person or persons to act as its representative(s) at the AGM. In accordance with the provisions of the Companies Act 2006, each such representative may exercise (on behalf of the corporation) the same powers as the corporation could exercise if it were an individual shareholder of the Company, provided that they do not do so in relation to the same shares.
13. Shareholders satisfying the thresholds in section 527 of the Companies Act 2006 can require the Company to publish a statement on its website setting out any matter relating to the audit of the Company's accounts (including the auditor's report and the conduct of the audit) that are to be laid before the AGM that the shareholders propose to raise at the AGM. The Company may not require the shareholders requesting the publication to pay its expenses. Any statement placed on the website must also be sent to the Company's auditor no later than the time it makes its statement available on the website. The business which may be dealt with at the AGM includes any statement that the Company has been required to publish on its website.
14. Under section 319A of the Companies Act 2006, the Company must, subject to limited exceptions, answer any question relating to the business being dealt with at the AGM which is put by a shareholder attending the AGM. Information relating to the AGM which the Company is required by the Companies Act 2006 to publish on a website in advance of the meeting may be viewed at www.osb.co.uk on the 'Shareholder Information' page. You may not use any electronic address provided in this notice to communicate with the Company for any purposes other than those expressly stated.
15. As at 24 March 2017 (being the latest practicable date before the publication of this document), the Company's issued share capital consisted of 243,082,091 ordinary shares, carrying one vote each. The Company did not hold any shares in treasury at that date. Therefore as at 24 March 2017 the total voting rights in the Company were 243,082,091.
16. The doors will open at 10.30 am and you may wish to arrive by 10.45 am to enable you to take your seat in good time.
17. If you have any special needs or require wheelchair access to the AGM venue, please contact Melissa Davies, melissa.davies@osb.co.uk or 01634 888 210 in advance of the AGM.
APPENDIX
Director Biographies
| Appointment | Committee membership | Key skills | Experience & qualifications | |
| Andrew Golding Chief Executive Officer | Andy was appointed to the Board in December 2011. | None. | Andy has over 30 years' experience in financial services. | Andy was previously CEO of Saffron Building Society, where he had been since 2004. Prior to that he held senior positions at NatWest, John Charcol and Bradford & Bingley. He is a Non-executive of Kreditech Holding SSL GmbH and currently holds a number of posts with industry institutions including membership of the Council of Mortgage Lenders Executive Committee. He is also a Director of the Building Societies Trust and has also served as a Non-Executive Director for Northamptonshire NHS. |
| April Talintyre Chief Financial Officer | April was appointed to the Board in May 2012. | Member of the Risk Committee. | April has broad financial services experience. She has been a member of the Institute of Chartered Accountants in England and Wales since 1992. | April was previously an Executive Director in the Rothesay Life pensions insurance business of Goldman Sachs and worked for Goldman Sachs International for over 16 years, including as an Executive Director in the Controllers division in London and New York. April began her career at KPMG in a general audit department. |
| Timothy Hanford Non-Executive Director | Tim was appointed to the Board in February 2011. | Member of the Nomination and Governance Committee. | Tim has over 25 years' experience in banking and investment, including in credit strategies, risk management, mergers and acquisitions. | Tim is Managing Director of J.C. Flowers & Co. UK Ltd. Previously, he was Head of Private Equity at Dresdner Bank and a member of the Institutional Restructuring Unit's Executive Committee. Tim has also served as a Board Director of Schroders, based in Hong Kong and Tokyo, where he was responsible for structured finance. |
| Margaret Hassall* Non-Executive Director | Margaret was appointed to the Board in July 2016. | Member of the Risk Committee. | Margaret brings a broad range of experience developed across various industry sectors including manufacturing, utilities, and financial services. | Margaret spent seven years working for Deloitte and Touche as a consultant and led the financial services consulting business for Charteris Plc. More latterly Margaret has been engaged as chief operations officer or chief information officer for divisions within some of the world's largest banks, namely Bank of America Merrill Lynch, Barclays and RBS. Margaret is a Non-Executive director for Ascension Trust (Scotland). |
| Rodney Duke* Senior Independent Non-Executive Director | Rod was appointed to the Board in July 2012 and was appointed Senior Independent Director in 2014. | Chair of the Nomination and Governance Committee and member of the Remuneration Committee. | Rod has extensive experience in operations, investments, risk management and corporate finance across retail and commercial banking. | Rod was previously Group General Manager, HSBC with responsibility for UK distribution - branches, call centres and internet banking - for both personal and commercial customers. Rod was with HSBC for 33 years. Previous directorships include VISA (UK), HFC Bank plc and HSBC Life. He also served on the Board of Alliance & Leicester plc until its takeover by Santander. Rod is a Fellow of the Institute of Financial Services. |
| Andrew Doman* Non-Executive Director | Andrew was appointed to the Board in July 2016. | Member of the Risk and Audit Committees. | Andrew is an experienced financial services executive. | Andrew is currently Chairman at Castle Trust Capital plc and was previously CEO of Premium Credit Limited and CEO, President and later Chairman of Frank Russell Company. He was also a senior director of McKinsey & Company, management consultants, based in the London office. He focused on the financial services sector, serving a number of leading banks, insurance companies and asset managers across a wide range of topics including strategy, performance improvement and risk. He was formerly a Non-Executive director of The Wesleyan. |
| Mary McNamara* Non-Executive Director | Mary was appointed to the Board in May 2014. | Chair of Remuneration and member of Risk and Nomination and Governance Committees. | Mary has broad senior management experience in the banking and finance sectors. | Mary is a Non-Executive Director of Dignity plc and Motorpoint plc. She was previously CEO of the Commercial Division and Board Director of the Banking Division at Close Brothers Group plc. Prior to that, Mary was COO of Skandia, the European arm of Old Mutual Group and prior to that, Mary spent 17 years at GE Capital, running a number of businesses including GE Fleet Services Europe and GE Equipment Finance. |
| John Graham Allatt* Non-Executive Director | Graham was appointed to the Board in May 2014. | Chairman of the Risk Committee and member of the Audit Committee. | Graham has significant banking and credit risk experience and financial services experience. | Graham was previously Acting Group Credit Director at Lloyds TSB and Chief Credit Officer at Abbey National. Prior to this he spent 18 years in the NatWest Group culminating in the role of Managing Director, Credit Risk at NatWest Markets. A Fellow of the Institute of Chartered Accountants, Graham is Deputy Chairman of the Friends of the British Library and was involved in housing associations for nearly 30 years as Treasurer and Board member in the North of England and in London. |
| Nathan Moss* Non-Executive Director | Nathan was appointed to the Board in May 2014. | Member of Remuneration, Audit and Nomination and Governance Committees. | Nathan is a business development and marketing specialist and has worked extensively in the banking sector. | Nathan was previously Group Strategy Director at Friends Life from 2010 to 2013 and Prior to that Nathan was Managing Director of Wealth Management at Lloyds TSB Group having joined Scottish Widows in 2002 as Managing Director, Marketing & Distribution. Prior to this he spent 18 years with HSBC Group including four years as General Manager, Personal Financial Services and culminating as COO of Merrill Lynch HSBC. Nathan is a Non-Executive Director of Homeserve Membership Ltd and Canada Life Group (UK) Ltd. |
| Eric Anstee* Non-Executive Director | Eric was appointed to the Board in December 2015. | Chairman of the Audit Committee and member of the Risk Committee. | Eric has extensive corporate finance and Mergers & Acquisitions experience over a broad range of business sectors. He is a member of the Takeover Panel Appeals Board and Visiting Professor, London Metropolitan University Business School. | Eric was Chairman of CPP Group plc from 2014 to 2015. Prior to this he was Chief Executive of the City of London Group plc, the first Chief Executive of the Institute of Chartered Accountants in England and Wales and Group Finance Director of Old Mutual plc. Eric was also Group Finance Director at The Energy Group plc and advisor to Lord Hanson on the Demerger of Hanson plc. Prior to this Eric spent 17 years at Ernst & Young. Eric is also a Non-Executive director of Sun Life Financial of Canada Limited, Insight Asset Management and Vocalink Limited. |
OneSavings Bank plc
Reliance House
Sun Pier
Chatham
Kent ME4 4ET
+44 (0)1634 838973
www.osb.co.uk